|1.||Irie, Kaoru: 1 article (07/2013)|
|2.||Tamura, Kei: 1 article (07/2013)|
|3.||Ozawa, Shogo: 1 article (07/2013)|
|4.||Yoshida, Midori: 1 article (07/2013)|
|5.||Kodama, Yukio: 1 article (07/2013)|
|6.||Takahashi, Miwa: 1 article (07/2013)|
|7.||Matsuo, Saori: 1 article (07/2013)|
|8.||Nishikawa, Akiyoshi: 1 article (07/2013)|
|9.||Inoue, Kaoru: 1 article (07/2013)|
|10.||Šiviková, Katarína: 1 article (01/2013)|
|1.||Chromosome Aberrations (Chromosome Abnormalities)
07/31/2013 - "To clarify the dose-response relationship between constitutive androstane receptor (CAR) activity and induction of cytochrome P450 2B (CYP2B) expression and hypertrophy by triazole fungicides in mouse liver, three dose levels of cyproconazole (Cypro), tebuconazole (Teb), fluconazole (Flu), and phenobarbital (PB), a typical CYP2B inducer, were administrated in diet to male wild-type (WT) and CAR-knockout (CARKO) mice for one week. "
|4.||Body Weight (Weight, Body)
04/01/2008 - "Tebuconazole and propiconazole demonstrated no antiandrogenic effects at doses between 50 and 150 mg/kg body weight/day in the Hershberger assay. "
04/01/2008 - "Initially, the antiandrogenic effects of propiconazole and tebuconazole (50, 100 and 150 mg/kg body weight/day each) were examined in the Hershberger assay. "
|4.||Cytochrome P-450 Enzyme System (Cytochrome P450)
|5.||constitutive androstane receptor